Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 29 May 2009, doi:10.1136/bmj.b1773
Cite this as: BMJ 2009;338:b1773
Philippa C Matthews, specialist registrar infectious diseases/microbiology, clinical research fellow1,2,3, Anthony R Berendt, consultant in infectious diseases1,2, Martin A McNally, consultant orthopaedic surgeon in limb reconstruction1, Ivor Byren, consultant in infectious diseases1,2
1 Bone Infection Unit, Nuffield Orthopaedic Centre NHS Trust, Headington, Oxford OX3 7LD, 2 Department of Infectious Diseases, Oxford Radcliffe Hospitals NHS Trust, John Radcliffe Hospital, Headington, Oxford OX3 9DU, 3 University of Oxford, Peter Medawar Building for Pathogen Research, Oxford OX1 3SY
Correspondence to: P C Matthews p.matthews@doctors.org.uk
| The first 150 words of the full text of this article appear below. |
Joint replacement is safe, cost effective,1 and widely undertaken. Most prosthetic joint replacements are hips and knees; more than 130 000 people underwent such procedures in England and Wales in the 12 months from April 2006.w1 Subsequent prosthetic joint infection is uncommon—the incidence varies between 0.6% and 2% per joint per year.2 3 4 5 However, this complication is associated with substantial morbidity and economic cost ($30 000 (£20 500;
22 800) to $50 000 per patient).3 4 6 w2 The diagnosis of prosthetic joint infection is difficult,w2 because symptoms, signs, and investigations may all be non-specific.7 w3 Defining diagnostic criteria and optimum management is complicated by patient heterogeneity and the small numbers in many published studies.w4 However, prompt recognition and diagnosis of prosthetic joint infection facilitates timely intervention to salvage infected joints, preserve joint function, prevent morbidity, and reduce costs.
|
Read all Rapid Responses